Browsing by Subject "Chronic Myeloid Leukemia"
Now showing items 1-1 of 1
-
Real-world incidence of severe myelosuppression among chronic myeloid leukemia patients treated with imatinib in Ontario
(2024-04-29)Imatinib, approved in 2001 for the treatment of chronic myeloid leukemia (CML) based on its remarkable efficacy, was associated with severe hematologic adverse events in clinical trials. This population-based retrospective ...